Four Tree Island Advisory, a major shareholder of DoubleDown Interactive (DDI), has called on the special committee of DDI's board to reject controlling shareholder DoubleU Games' takeover proposal of $11.25 per ADS. The advisory argues the offer significantly undervalues the company, assigning little to no value to DDI's operating business despite improved EBITDA and strategic acquisitions since 2021. They highlight that DoubleU Games' previous acquisitions valued DDI much higher, and the current offer benefits DoubleU Games disproportionately by cutting public company expenses without sharing savings with minority shareholders. Four Tree Island Advisory urges an independent appraisal to ensure any proposal fairly reflects DDI's intrinsic value and encourages minority shareholders to voice their concerns.
A new report reveals more than 180 companies are actively developing over 200 PD-1 and PD-L1 inhibitors, a class of immunotherapies that boost the immune system to fight cancer. These drugs target various cancers including lung, bladder, liver, and e...
Eversource has been recognized on TIME's list of America's Best Companies for 2026, highlighting its strong commitment to employee satisfaction, operational excellence, and sustainability. The ranking is based on surveys of over 217,000 employees and...
The head and neck squamous cell carcinoma (HNSCC) market is projected to grow at a compound annual growth rate (CAGR) of 10.5% from 2026 to 2036, fueled by rising cancer incidence and the introduction of novel immunotherapies and targeted treatments....
Poolside has released Laguna S 2.1, a 118-billion-parameter open-weight AI model designed for agentic coding that matches or outperforms much larger models. It is compact enough to run on a single NVIDIA DGX Spark desktop and is available under an op...
Pomerantz LLP is investigating Omeros Corporation for potential securities fraud following a significant stock price drop. The decline occurred after the European Medicines Agency's Committee for Medicinal Products for Human Use issued a negative opi...
